Implement the main responsibility of the company's safety production, effectively enhance the safety production awareness and management level of the company's main responsible persons and safety management personnel, and prevent and reduce the occurrence of various accidents.
On the morning of March 1, Kangyuxin Biosafety Equipment Department organized the heads of all departments to study the Notification of the Office of The State Council Safety Committee on the two typical accidents during the Spring Festival and the 2.22 coal mine accident in Inner Mongolia. Wang Youwei, the general manager in charge of our company, took the lead in learning and preaching safety education. The company's middle-level assistants and above, and the security directors of all departments participated in the training.
The purpose of this training is to make the company's owners to the responsible person and safety management personnel learn to understand the current situation of safety production, familiar with the relevant policies, laws and regulations of safety production, clear the current and future focus on safety production work, master the method of safety production work in the new era, and strive to improve the level of enterprise safety production management. In order to promote the company's safety production situation continued stability.
Through training, the company's main person in charge and safety management personnel have further improved their safety ideology, quality and skills, timely understand the laws, regulations and policy priorities of safety production work, improve the level of enterprise safety management, fully mobilize the enterprise to improve the essential level of safety production and prevent all kinds of accidents, initiative and initiative, in order to effectively implement the main responsibility of the enterprise, Preventing all kinds of accidents has played a positive role in promoting.
Kang Yu Xin biological
Kangyuxin Biotechnology Co., Ltd. was established in October 2013, specializing in the research and development, production, sales and related service technology development of pyrazine intermediates and process libraries. Kangyuxin has more than 2,000 square meters of standardized laboratories, with an output value of more than 80 million yuan in 2022. The core technology of pyrazine derivatives of Kangyuxin ranks the leading level in China, and the varieties and orders of pyrazine series products are ranked first in the domestic industry. Kangyuxin has an experienced and high-quality drug process research and development team, which can realize the research and development and process production from lead compounds to clinical batch apis. Kangyuxin Drug Quality research team can provide effective data and method validation for drug registration and research.
The company was supported by the innovation Fund of Gansu Province in 2016, and was identified as the first batch of provincial science and technology innovation enterprises by the Department of Science and Technology of Gansu Province, and has been supported by the science and technology innovation Fund of Lanzhou and Baiyin for many times. Wang Youwei, the founder of the company, was named "One hundred innovative and entrepreneurial models in Lanzhou City" in 2015. Kangyuxin, as the first domestic enterprise to develop a broad spectrum antiviral new drug "Fapiravir", was shortlisted in the eighth batch of key protection enterprises for epidemic prevention materials in Gansu Province. Kangyuxin won the Excellence Award of the 10th China Innovation and Entrepreneurship Competition National Biomedical Industry Competition in 2021 (the second place in the group), and the second place in the Gansu Division of the 10th China Innovation and Entrepreneurship Competition. Won the first prize in the Northwest region of the 2020 "Guotong Cup" Lanzhou University Global Alumni Entrepreneurship Competition, and the first prize of the Baiyin Double Innovation Competition for two consecutive years in 2020 and 2021. In 2022, it will be evaluated as a high-tech enterprise and a specialized and special new enterprise.
